Medindia

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Dec. 16 Anesiva,Inc. (Nasdaq: ANSV) today announced top-line results showing that the Phase 3trial evaluating Adlea(TM), its long-acting, non-opioid analgesic ...
Fierce Healthcare

Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application

Adlea's short duration of systemic exposure relative to the longer duration of analgesia may offer a safe, additive treatment option in the management of post-surgical orthopedic pain, as well as pain ...
Medindia

Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Sept. 13 Anesiva,Inc. (Nasdaq: ANSV) today announced that it has initiated a new Phase 2 studyof Adlea(TM) (formerly 4975) for the relief of post-operative pain in ...
FierceBiotech

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring Conference Call Scheduled for November 11, 2008 at 9:00 am ET; Cuts 15 Employees ...
Finanznachrichten

Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea (formerly 4975) in Osteoarthritis of the Knee

SOUTH SAN FRANCISCO, Calif., July 2 /PRNewswire-FirstCall/ -- Anesiva, Inc. today announced preliminary longer-term, follow-up results from a Phase 2 study showing ...
Reuters

Anesiva defines regulatory pathway for Adlea with FDA; new Phase 3 plan could expedite clinical development pathway

Co announced that it will conduct two Phase 3 clinical trials for the approval of Adlea, one of which has already been planned in total knee replacement surgeries- and the second trial in bunionectomy ...
The Business Journals

Anesiva seeks partner to salvage pain drug

Anesiva Inc. may be down to its last shot to translate pain into gain. The South San Francisco pain drug company, the recipient of a â going concernâ letter from its auditor late last month, took the ...
BioWorld

Anesiva Restructures Following Setbacks with Adlea and Zingo

The trade secret dispute between Acton, Mass.-based Insulet Corp. and Eoflow Co. Ltd., of Seongnam, South Korea, addresses several key questions in the area of ...
FierceBiotech

Anesiva, Inc. Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV - News) today announced top-line results showing that the Phase 3 trial ...
Reuters

Anesiva announces Phase 2 data showing substantial, long-term pain reductions with Adlea in osteoarthritis of the knee

Co announces preliminary longer-term, follow-up results from a Phase 2 study showing that a 1mg treatment with Adlea in patients with moderate-to-severe osteoarthritis of the knee produced substantial ...